Brian Mann

Updated July 21, 2021 at 3:55 PM ET

A bipartisan coalition of state attorneys general announced on Wednesday a $26 billion national settlement with drugmaker Johnson & Johnson and three companies that distributed opioid painkillers even as addiction and overdose deaths skyrocketed.

"The opioid epidemic has torn families apart and killed thousands of North Carolinians," said North Carolina state Attorney General Josh Stein, one of the lead negotiators.

Updated July 20, 2021 at 6:26 PM ET

A landmark national opioid settlement now being finalized would provide as much as $26 billion to states and communities struggling to respond to the opioid crisis.

That's according to a team of attorneys representing governments involved in the litigation who briefed reporters Tuesday.

Sources have told NPR a final deal could be reached as early as this week, but details are still being negotiated.

Updated July 19, 2021 at 10:56 PM ET

The U.S. Justice Department is condemning a proposed bankruptcy settlement for Purdue Pharma, the maker of Oxycontin. In court filings Monday, two divisions of the DOJ described the plan as fatally flawed.

The DOJ's U.S. Trustee program, which serves as a national watchdog over the federal bankruptcy system, said the deal is unconstitutional and illegal.

Nine months before a massive section of Champlain Towers South in Surfside, Fla., came showering down, an engineering firm called Morabito Consultants found "severely deteriorated" concrete throughout the building, including in load-bearing structures known as corbels.

Updated July 8, 2021 at 7:57 AM ET

Fifteen states that led the effort to block a controversial bankruptcy plan for OxyContin-maker Purdue Pharma have abandoned the fight.

That's according to court documents filed by a mediator late Wednesday as part of a federal bankruptcy proceeding in White Plains, N.Y.

Among the states that have agreed to sign on to the bankruptcy deal are Massachusetts and New York, whose attorneys general had mounted fierce legal opposition to the agreement.

Just weeks before Champlain Towers South collapsed, town officials in Surfside, Fla., were demanding immediate changes on the property — but all of their requirements focused on relatively minor concerns.

A poolside gate needed repair. A hedge had to be trimmed to accommodate emergency vehicles. Paving stones had to be replaced.

Just one month after an engineering report warned of "major structural damage" that required immediate repair, a Surfside, Fla., official assured residents of Champlain Towers South that their building was sound.

Updated June 26, 2021 at 5:56 PM ET

A structural engineering report provided to the Champlain Towers condominium association in 2018 found widespread problems that required extensive repairs "in the near future."

The consulting group that wrote the report noted Saturday that the document "detailed significant cracks and breaks in the concrete, which required repairs to ensure the safety of the residents and the public."

Every time Shani Damron, 34, buys methamphetamines or heroin on the streets of Huntington, W.Va., she knows the risk is extreme.

"That fentanyl is no joke," Damron said, referring to the deadly synthetic opioid that now contaminates much of the illegal drug supply in the United States. "Every time we stick a needle in our arm, we're taking a 50-50 chance. We could die."

There's also a high risk of disease from contaminated needles shared by drug users. Damron's community has seen a major HIV/AIDS outbreak.

When Aaron Hinton walked through the housing project in Brownsville on a recent summer afternoon, he voiced love and pride for this tightknit, but troubled working-class neighborhood in New York City where he grew up.

He pointed to a community garden, the lush plots of vegetables and flowers tended by volunteers, and to the library where he has led after-school programs for kids.

But he also expressed deep rage and sorrow over the scars left by the nation's 50-year-long War on Drugs. "What good is it doing for us?" Hinton asked.

After more than a year of high-stakes negotiations with billions of dollars on the line, a bankruptcy plan for Purdue Pharma, the maker of OxyContin, cleared a major hurdle late Wednesday.

Federal Judge Robert Drain in White Plains, N.Y., moved the controversial deal forward despite objections from dozens of state attorneys general, setting the stage for a final vote by the company's creditors expected this summer.

The drugmaker filed for Chapter 11 protection in 2019 facing an avalanche of lawsuits tied to its aggressive opioid sales practices.

During years when the prescription opioid epidemic was spiraling out of control, corporate executives at the drug wholesaler McKesson sent at least two memos ordering employees to "refrain from using the word 'suspicious'" to describe escalating opioid orders from pharmacy chains.

The documents were disclosed this week as part of a landmark federal opioid trial now underway in West Virginia, one of the states hit hardest by opioid deaths.

Updated May 3, 2021 at 9:51 PM ET

A senior Drug Enforcement Administration official told NPR efforts to target drug cartels operating inside Mexico have unraveled because of a breakdown in cooperation between law enforcement agencies and militaries in the two countries.

For months, members of the Sackler family that owns Purdue Pharma, the maker of Oxycontin, have portrayed their bid for immunity from future opioid lawsuits as a kind of fait accompli, a take-it-or-leave-it fix to a legal morass.

The Biden administration says new federal guidelines released Tuesday will allow far more medical practitioners to prescribe buprenorphine, a drug proven to reduce opioid relapses and overdose deaths.

The change lowers regulatory hurdles that critics believe sharply limit use of the life-saving medication at a time when drug deaths are surging.

"We have made this much easier for physicians but also for other medical practitioners," said Dr. Rachel Levine, assistant secretary of health, speaking with NPR.

Pages